Connecticut Proton Therapy Center selects RayCare

1 year ago

STOCKHOLM, Aug. 21, 2024 /PRNewswire/ -- RaySearch Laboratories AB (publ) is pleased to announce that the Connecticut Proton Therapy Center, Wallingford,…

Limmi adds nationally recognized expert in early disease detection and microbiome biology to Advisory Board

1 year ago

CARLSBAD, Calif., Aug. 21, 2024 /PRNewswire/ -- Today, Limmi – an AI startup dedicated to transforming patient outcomes by rapidly discovering…

Wolters Kluwer adds patient case active learning tool to nursing education offerings

1 year ago

Lippincott Client Cases for Clinical Judgment sparks clinical competency and thinking skills of nursing studentsWALTHAM, Mass.--(BUSINESS WIRE)--Wolters Kluwer Health continues…

Wolters Kluwer adds patient case active learning tool to nursing education offerings

1 year ago

Lippincott Client Cases for Clinical Judgment sparks clinical competency and thinking skills of nursing studentsWALTHAM, Mass.--(BUSINESS WIRE)--Wolters Kluwer Health continues…

Positive Interim Blood Sugar Results from Lexaria’s GLP-1 Diabetes Animal Study

1 year ago

DehydraTECH-liraglutide is showing apparent superiority to DehydraTECH-semaglutideSelect DehydraTECH-CBD formulations are showing apparent superiority to DehydraTECH-GLP-1 at 4 and 8 weeks…

Formula Wellness Partners with Radiance Medical Aesthetics & Wellness, Expanding Longevity Services in The Woodlands, TX

1 year ago

DALLAS, TX / ACCESSWIRE / August 21, 2024 / Formula Wellness, a Trive Capital portfolio company offering a new approach…

Sonoma Pharmaceuticals Announces Partnership with Global Healthcare Distributor for Distribution of Wound Care Products in the United States

1 year ago

BOULDER, CO / ACCESSWIRE / August 21, 2024 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader developing and producing…

Biotricity Reports Continued Margin Improvement and Reduced Losses in its First Quarter Fiscal Year 2025

1 year ago

The Company shows continued progress towards cash-flow break even and profitabilityRecurring Technology Fee (SaaS) revenue - over 94% of total…

Theralase(R) Demonstrates Unique Ability to Activate Rutherrin(R) With Diabetes Drug

1 year ago

TORONTO, ON / ACCESSWIRE / August 21, 2024 / Theralase® Technologies Inc. ("Theralase®" or the "Company") (TSXV:TLT)(OTCQB:TLTFF), a clinical stage…